MS vs UNH: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Morgan Stanley · Financial Services
$189.30
-30.5% upside to fair value
Grade C
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$304.33
+41.3% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
UNH has more upside to fair value
(+41.3%).
UNH trades at a lower forward P/E
(15.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
UNH |
| Current Price |
$189.30 |
$304.33 |
| Fair Value Estimate |
$131.49 |
$430.00 |
| Upside to Fair Value |
-30.5%
|
+41.3%
|
| Market Cap |
$300.6B |
$276.2B |
| Forward P/E |
16.4x
|
15.1x
|
| EV / EBITDA |
24.4x
|
14.3x
|
| Price / Sales |
2.5x
|
0.6x
|
| Price / FCF |
-16.8x
|
17.2x
|
| Revenue Growth YoY |
+18.8%
|
+11.8%
|
| Gross Margin |
58.0%
|
18.5%
|
| Operating Margin |
19.5%
|
4.2%
|
| Return on Equity |
16.7%
|
12.7%
|
| Dividend Yield |
0% |
2.9% |
| FCF Yield |
—
|
5.82%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%…
UnitedHealth Group is the world's largest diversified healthcare company, combining the dominant US health insurer UnitedHealthcare with the high-margin Optum services platform spanning care delivery, pharmacy benefits, and data analytics. The stock has fallen roughly 49% from its 2024 peak of $596, driven by elevated medical costs, DOJ antitrust scrutiny, CEO transitions (Brian Thompson's murder…
Accumulation Zones
| Metric |
MS |
UNH |
| Zone Low |
$98.62 |
$280.00 |
| Zone High |
$111.77 |
$340.00 |
| In Buy Zone? |
No
|
Yes
|